Study: Cannabis use did not reduce TMS benefits for depression
A new peer-reviewed analysis of 745 adults found that cannabis use did not meaningfully change outcomes from transcranial magnetic stimulation for depression. Patients improved in depression, anxiety and quality of life, while self-reported cannabis use also declined during treatment.
Why it matters: - The findings address a common clinical question: whether cannabis use makes TMS less effective for depression. - The study suggests patients who use cannabis can still benefit from TMS without being excluded from treatment. - The decline in self-reported cannabis use during treatment may help clinicians think about when to screen for substance use during a TMS course.
What happened: - Researchers reviewed outcomes for 745 adults who completed a full 30-session TMS course at Family Care Center. - The results were published in a peer-reviewed letter to the editor in the journal Brain Stimulation. - Patients improved in depression, anxiety and quality of life whether or not they used cannabis. - Self-reported cannabis use fell during treatment.
The details: - At baseline, 160 patients, or 21.5%, reported cannabis use. - Among patients with baseline PHQ-9 scores of 10 or higher (n = 675), self-reported cannabis use fell from 21.9% to 16.1% by the 30th session. - Most of the decline happened by about the midpoint of treatment, around session 15. - Depression, anxiety and quality-of-life scores improved significantly from the start to the 30th session for both cannabis users and non-users, with all p < .001. - Researchers found no significant difference in improvement between cannabis users and non-users, even after adjusting for baseline differences, with p = 0.54. - The analysis used linear mixed-effects models and propensity score methods to account for age and other baseline differences. - Cannabis users were younger on average than non-users, with mean ages of 36.4 and 44.4. - Cannabis users also reported lower quality of life at the start of treatment. - The main predictors of improvement were treatment itself and baseline depression severity, with greater gains among patients who started with more severe symptoms. - Researchers did not detect a link between changes in cannabis use and changes in depression in either direction. - The study says this is the first real-world clinical analysis to characterize cannabis use among patients receiving TMS for major depressive disorder.
Between the lines: - The results are reassuring for clinics that treat patients with both depression and cannabis use. - The study does not prove TMS caused the drop in cannabis use, and the authors call for further investigation. - The analysis relied on self-reported cannabis use, so objective testing would strengthen future research. - The findings fit with broader evidence that depression and cannabis use often overlap. - The article cites research showing about 25% of cannabis users have a depressive disorder and nearly one in five has major depressive disorder.
What's next: - The authors say larger randomized studies are needed to confirm the findings. - Future research should use objective measures such as toxicology testing to track cannabis use. - The study suggests TMS programs may want to assess substance use during treatment, especially around the middle of a course. - Family Care Center says the results add to understanding of how TMS can support patients with different experiences and needs.
The bottom line: - Cannabis use did not appear to reduce the benefits of TMS for depression in this real-world study.
Disclaimer: This article was produced by AGP Wire with the assistance of artificial intelligence based on original source content and has been refined to improve clarity, structure, and readability. This content is provided on an “as is” basis. While care has been taken in its preparation, it may contain inaccuracies or omissions, and readers should consult the original source and independently verify key information where appropriate. This content is for informational purposes only and does not constitute legal, financial, investment, or other professional advice.
Sign up for:
Educators Post Observer
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.